Sign in / Join Now
ETFs & Funds
Despite Monday's 26% surge, Keryx Biopharmaceuticals (
) is still way off its high a month ago.
will hit it this time with Zerenex, not as big of a market value as was leading up w/ failed Perifosine. It will make a run, $3-4 imo
Add a reply...
Latest StockTalks »
people get KERX breaking news and analysis by email alert.
Get email alerts on KERX »
Keryx Biopharmaceuticals, Inc.
Get latest price
From other sites
October 3rd Deadline Alert: GPM Reminds Investors Of The Upcoming Deadline In The Class Action Lawsuit Against Keryx Pharmaceuticals, Inc. And Announces Expanded Class Period
at TheStreet (Tue, 4:08PM)
KERX Crosses Above Key Moving Average Level
at TheStreet (Thu, 1:06PM)
Keryx Biopharmaceuticals To Webcast Its Presentation At Ladenburg Thalmann's 2016 Healthcare Conference
at TheStreet (Sep 21, 2016)
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Keryx Biopharmaceuticals, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of October 3, 2016
at TheStreet (Sep 19, 2016)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Keryx Biopharmaceuticals, Inc. Of Upcoming Deadline
at TheStreet (Sep 16, 2016)